Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $187.22 USD
Change Today +0.48 / 0.26%
Volume 16.2K
JAZZ On Other Exchanges
As of 9:41 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce C. Cozadd

Co-Founder, Executive Chairman and Chief Executive Officer, Jazz Pharmaceuticals Public Limited Company
AgeTotal Calculated CompensationThis person is connected to 105 board members in 5 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Bruce C. Cozadd co-founded Jazz Pharmaceuticals Public Limited Company (also known as Jazzpharmaceuticals, Inc.) in 2003 and has been its Executive Chairman and Chief Executive Officer since January 2012. Mr. Cozadd serves as the Chairman and Chief Executive Officer at Azur Pharma Limited. He served in various executive management positions with ALZA Corporation from 1991 to 2001, including Vice President of Corporate Planning and Analysis. He served as Executive ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4


Phone: 353 1 634 7800
Fax: 353 1 634 7850

Board Members Memberships*

Chairman, Chief Executive Officer, Chairman of Jazz Pharmaceuticals, Inc. and Chief Executive Officer of Jazz Pharmaceuticals, Inc.
Director and Chairman of Audit Committee
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
Director and Member of Compensation Committee
Co-Founder, Executive Chairman and Chief Executive Officer


Yale University
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

Total Annual Compensation$771,154

Stock Options*

Restricted Stock Awards$2,956,500
All Other Compensation$3,622
Exercised Options49,934
Exercised Options Value$1,871,838
Exercisable Options71,747
Exercisable Options Value$5,900,002
Unexercisable Options267,044
Unexercisable Options Value$20,061,817
Total Value of Options$27,833,656
Total Number of Options388,725

Total Compensation*

Total Annual Cash Compensation$1,831,276
Total Short Term Compensation$771,154
Other Long Term Compensation$2,960,122
Total Calculated Compensation$8,266,526
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JAZZ:US $187.22 USD +0.48


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
Rajat Rai Chief Executive Officer
Akorn, Inc.
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at